Navigation Links
Valeant Pharmaceuticals To Announce 2013 Second Quarter Results On August 7, 2013
Date:7/15/2013

LAVAL, Quebec, July 15, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Wednesday, August 7, 2013 at 8:00 a.m. ET (5:00 a.m. PT) to discuss results for the 2013 second quarter.

The dial-in number to participate on this call is (877) 876-8393, confirmation code 17202469.  International callers should dial (973) 200-3961, confirmation code 17202469. A replay will be available approximately two hours following the conclusion of the conference call to Wednesday, August 14, 2013, and can be accessed by dialing (855) 859-2056 or (404) 537-3406, confirmation code 17202469.

The webcast and slide presentation will be hosted in the investor relations section of its corporate Web site at www.valeant.com. Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at www.valeant.com.

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics.  More information about Valeant can be found at www.valeant.com.

(Logo:  http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals Announces Closing of Public Offering of Common Shares
2. Valeant Pharmaceuticals Announces Exercise Of Over-Allotment Option
3. Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes
4. Valeant Pharmaceuticals Prices Public Offering Of Common Shares
5. Valeant Pharmaceuticals Announces Public Offering Of Common Shares
6. Valeant Pharmaceuticals Announces Filing Of Preliminary Base Shelf Prospectus
7. Valeant Pharmaceuticals Announces Receipt Of U.S. FDA Complete Response Letter For Efinaconazole
8. Valeant Pharmaceuticals Announces 2013 Annual Meeting Results
9. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
10. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
11. Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... CITY , Dec. 8, 2016 ... US patents for improving the accuracy, reproducibility and ... images in long and small bone orthopaedic applications. ... approach to creating personalized orthopaedic restorations based on ... personalized orthopaedic restorations, the company harnesses the world,s ...
(Date:12/8/2016)... 2016  A new study by a pair of ... opioid therapy to treat chronic pain is not only ... harmful consequences, including death. Palliative care physicians ... Mehta , M.D., authored the study which provides a ... The study was published in the December 2016 edition ...
(Date:12/8/2016)... December 8, 2016 Information products and services ... in Scopus , the world,s largest abstract and citation ... comprehensive metrics for journals from over 5,000 publishers. The new set ... to subscribe to and when to adjust a journal,s editorial strategy. ... , , ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... "I have gout, and I wanted to treat ... which is meant to relieve gout and pain caused by varicose veins. I drank ... every time. It relieved what VA doctors called the worst sinusitis case they'd seen ...
(Date:12/9/2016)... ... 2016 , ... An inventor from Cana, Va., wanted to fulfill the need ... park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It eliminates discrimination. ... set up in a matter of minutes, or even seconds. The SAFETY STRAP FOR ...
(Date:12/9/2016)... ... 2016 , ... MEDI+SIGN®, a provider of fully-automated patient monitoring ... for Emergency Departments (ED) has been added to their portfolio. Housed in a ... and with a simplified pallet of information available to the patient, the Digital ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... become Quality Insights beginning January 1, 2017. The name change aligns the ... to measuring and improving health care quality. , “We are very proud of ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Company LLC, announced the first national #QuackGivesBack campaign which supported local breast ... was our first franchise-wide Quack Gives Back initiative, and we’re very ...
Breaking Medicine News(10 mins):